| Application no. and date | 18768395.8 (espacenet) (Federated) (European Patent Register), 20180316 | | Patent/reg. no. and date | DK/EP 3596222, 20230412 | | Publication date | 20200122 | | Priority no. and date | US 201762473148 P, 20170317 | | EP pub. no. and date |
EP 3596222 20200122 | | Effective date | | | Applicant/owner | Research Institute at Nationwide
Children's Hospital, 700 Children's Drive
Columbus, Ohio 43205, US | | Applicant ref. no. | 1661016 | | Inventor | MENDELL, Jerry, R., 8176 Copperfield Drive
Columbus, OH 43235, US,
RODINO-KLAPAC, Louise, 5499 Lilac Ave.
Grove City, OH 43123, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C12N 15/09 (2006.01) , C12N 15/113 (2010.01) , C12N 15/86 (2006.01) | | Title | ADENOASSOCIERET VIRUSVEKTORFREMFØRING AF MUSKELSPECIFIK MIKRO-DYSTROPHIN TIL BEHANDLING AF MUSKELDYSTROFI | | Int. application no. | US2018022881 | | Int. publication no. | WO2018170408 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
